{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:50:19Z","timestamp":1772916619761,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004740","name":"Fondazione del Monte","doi-asserted-by":"publisher","award":["FDM2015"],"award-info":[{"award-number":["FDM2015"]}],"id":[{"id":"10.13039\/501100004740","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ijcard.2018.03.077","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T17:55:55Z","timestamp":1521395755000},"page":"204-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: Data from the Brisighella Heart Study cohort"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4367-3884","authenticated-orcid":false,"given":"Arrigo F.G.","family":"Cicero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-4347","authenticated-orcid":false,"given":"Masanari","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilisa","family":"Bove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7853-0042","authenticated-orcid":false,"given":"Federica","family":"Fogacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Rosticci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"D'Addato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8039-8781","authenticated-orcid":false,"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.03.077_bb0005","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/msj.21345","article-title":"Recognizing global burden of cardiovascular disease and related chronic diseases","volume":"79","author":"Kelly","year":"2012","journal-title":"Mt Sinai J. Med."},{"issue":"8","key":"10.1016\/j.ijcard.2018.03.077_bb0010","article-title":"Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries","volume":"4","author":"Uthman","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0015","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1152\/physrev.00004.2012","article-title":"Molecular biology of atherosclerosis","volume":"93","author":"Hopkins","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1476-511X-11-85","article-title":"Oxidized low density lipoprotein, stem cells, and atherosclerosis","volume":"11","author":"Yang","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2012.10.074","article-title":"Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis \u2014 a review of the experimental evidence","volume":"227","author":"Bj\u00f6rkbacka","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2018.03.077_bb0030","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/15257770902736400","article-title":"Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress","volume":"28","author":"Gersch","year":"2009","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.ijcard.2018.03.077_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.abb.2003.10.011","article-title":"Triuret: a novel product of peroxynitrite-mediated oxidation of urate","volume":"423","author":"Robinson","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2010.04.010","article-title":"Radicals in the reaction between peroxynitrite and uric acid identified by electron spin resonance spectroscopy and liquid chromatography mass spectrometry","volume":"49","author":"Imaram","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"21","key":"10.1016\/j.ijcard.2018.03.077_bb0050","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1074\/jbc.M116.767657","article-title":"Urate hydroperoxide oxidizes human peroxiredoxin 1 and peroxiredoxin 2","volume":"292","author":"Carvalho","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0055","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1021\/acs.chemrestox.5b00132","article-title":"Chemical characterization of urate hydroperoxide, a pro-oxidant intermediate generated by urate oxidation in inflammatory and photoinduced processes","volume":"28","author":"Patricio","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0060","doi-asserted-by":"crossref","unstructured":"Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson RJ, Henderson GN. Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic acids2008;27:967\u201378.","DOI":"10.1080\/15257770802257952"},{"key":"10.1016\/j.ijcard.2018.03.077_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2008.11.029","article-title":"Simultaneous determination of uric acid metabolites allantoin, 6-aminouracil, and triuret in human urine using liquid chromatography-mass spectrometry","volume":"877","author":"Kim","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0070","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1159\/000345509","article-title":"Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations","volume":"121","author":"Sanchez-Lozada","year":"2012","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0075","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/labinvest.2014.98","article-title":"Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and srebp-1c activation in hepatocytes","volume":"94","author":"Choi","year":"2014","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0014-5793(99)00231-8","article-title":"Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein","volume":"446","author":"Abuja","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0085","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1742-1241.2005.00621.x","article-title":"Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults","volume":"59","author":"Erdogan","year":"2005","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/HJH.0b013e328365b916","article-title":"For the Brisighella Heart Study group. Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study","volume":"32","author":"Cicero","year":"2014","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2008.02.024","article-title":"The paradoxical relationship between serum uric acid and cardiovascular disease","volume":"392","author":"Lippi","year":"2008","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.ijcard.2018.03.077_bb0100","first-page":"591","article-title":"Obesity in the young","volume":"74","author":"Borghi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0105","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2012.12.034","article-title":"Association of serum uric acid and cardiovascular disease in healthy adults","volume":"111","author":"Kivity","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2018.03.077_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5527\/wjn.v4.i1.83","article-title":"Lipid abnormalities in kidney disease and management strategies","volume":"4","author":"Pandya","year":"2015","journal-title":"World J Nephrol"},{"issue":"4","key":"10.1016\/j.ijcard.2018.03.077_bb0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000443443","article-title":"Combined association of serum uric acid and metabolic syndrome with chronic kidney disease in hypertensive patients","volume":"41","author":"Dai","year":"2016","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2459\/JCM.0b013e3283516798","article-title":"Leisure-time physical activity and cardiovascular disease mortality: the Brisighella heart study","volume":"13","author":"Cicero","year":"2012","journal-title":"J. Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2018.03.077_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejim.2015.02.007","article-title":"Serum uric acid and other short-term predictors of electrocardiographic alterations in the Brisighella Heart Study cohort","volume":"26","author":"Cicero","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ijcard.2018.03.077_bb0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2016.07.026","article-title":"Brisighella Heart Study Group. High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects","volume":"37","author":"Cicero","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ijcard.2018.03.077_bb0135","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-156-11-201203200-00391","article-title":"Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review","volume":"156","author":"Earley","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0140","first-page":"1","article-title":"Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10715768909073429","article-title":"Continuous monitoring of in vitro oxidation of human low density lipoprotein","volume":"6","author":"Esterbauer","year":"1989","journal-title":"Free Radic. Res. Commun."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0150","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.98.15.1487","article-title":"Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease","volume":"98","author":"Holvoet","year":"1998","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcard.2018.03.077_bb0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1301\/nr.2003.nov.363-375","article-title":"Lipoprotein metabolism in obesity and diabetes: insights from stable isotope kinetic studies in humans","volume":"61","author":"Marsh","year":"2003","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0160","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/hr.2009.154","article-title":"Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device","volume":"32","author":"Hickson","year":"2009","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/HJH.0b013e32835a8eb1","article-title":"Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure","volume":"31","author":"Pucci","year":"2013","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0170","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ypmed.2016.05.031","article-title":"Objectively measured physical activity, sedentary time and subclinical vascular disease: cross-sectional study in older British men","volume":"89","author":"Parsons","year":"2016","journal-title":"Prev. Med."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijcard.2015.02.011","article-title":"Increased aortic blood pressure augmentation in patients with congenital heart defects - a cross-sectional study in 1125 patients and 322 controls","volume":"184","author":"M\u00fcller","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcard.2018.03.077_bb0180","doi-asserted-by":"crossref","first-page":"661","DOI":"10.20452\/pamw.2548","article-title":"Brisighella Heart Study Group: serum uric acid and markers of LDL-oxidation in non-smoker healthy subjects: data from the Brisighella Heart Study","volume":"124","author":"Cicero","year":"2014","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0185","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.ki.5000047","article-title":"Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease","volume":"69","author":"Briet","year":"2006","journal-title":"Kidney Int."},{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2018.03.077_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1185\/03007995.2015.1087979","article-title":"Why focus on uric acid?","volume":"31","author":"Johnson","year":"2015","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.ijcard.2018.03.077_bb0195","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000464260","article-title":"Elevated serum uric acid level predicts rapid decline in kidney function","volume":"45","author":"Kuwabara","year":"2017","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"10.1016\/j.ijcard.2018.03.077_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0b013e32834d54ca","article-title":"Nitric oxide synthase derangements and hypertension in kidney disease","volume":"21","author":"Baylis","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.freeradbiomed.2009.11.012","article-title":"Hydrogen peroxide is the major oxidant product of xanthine oxidase","volume":"48","author":"Kelley","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V89.2.577","article-title":"The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice","volume":"89","author":"Netea","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ijcard.2018.03.077_bb0215","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1681\/ASN.2016050521","article-title":"Vascular function and uric acid-lowering in stage 3 ckd","volume":"28","author":"Jalal","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/HYPERTENSIONAHA.116.08488","article-title":"Effect of uric acid-lowering agents on endothelial function: a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Borgi","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2018.03.077_bb0225","article-title":"Effects of allopurinol on endothelial function: a systematic review and meta-analysis of randomized placebo-controlled trials","author":"Cicero","year":"2017","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ijcard.2018.03.077_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091961","article-title":"Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study","volume":"9","author":"Ng","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijcard.2018.03.077_bb0235","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2796.2010.02277.x","article-title":"Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk","volume":"268","author":"Holewijn","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.diabres.2014.02.005","article-title":"Brisighella Heart Study group. Long-term predictors of impaired fasting glucose and type 2 diabetes in subjects with family history of type 2 diabetes: a 12-years follow-up of the Brisighella Heart Study historical cohort","volume":"104","author":"Cicero","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ijcard.2018.03.077_bb0245","first-page":"69","article-title":"Brisighella Heart Study. Dietary determinants of oxidized-low-density lipoprotein antibodies in a sample of pharmacologically untreated non-smoker subjects: data from the Brisighella Heart Study","volume":"22","author":"Cicero","year":"2013","journal-title":"Adv. Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2018.03.077_bb0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000441091","article-title":"Plasma xanthine oxidase activity is predictive of cardiovascular disease in patients with chronic kidney disease, independently of uric acid levels","volume":"131","author":"Gondouin","year":"2015","journal-title":"Nephron"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317377331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317377331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T21:22:02Z","timestamp":1751491322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317377331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":50,"alternative-id":["S0167527317377331"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.03.077","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: Data from the Brisighella Heart Study cohort","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.03.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}